Skip to main content

MARSHALL WACE, LLP

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1318757 LONDON, X0

Position in LFCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$217,076
-$687,803 QoQ
Shares Held
58,354
-47.2% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. LFCR ranks #28 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LFCR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $217,076 58,354
2025-12-31 $904,879 110,621
2025-09-30 $839,592 114,075
2025-06-30 $287,058 35,352
2025-03-31 $477,452 67,820
2024-12-31 $989,608 133,191
2024-09-30 $989,450 200,700
2024-06-30 $1,539,614 300,120
2024-03-31 $850,837 160,233
2023-12-31 $890,697 143,893
2023-09-30 $676,706 89,630
2023-06-30 $1,228,737 127,067
2021-12-31 $1,154 104